A SCOTTISH NATIONAL MORTALITY STUDY ASSESSING CAUSE OF DEATH, QUALITY OF AND VARIATION IN MANAGEMENT OF PATIENTS WITH TESTICULAR NONSEMINOMATOUS GERM-CELL TUMORS

被引:22
作者
HOWARD, GCW
CLARKE, K
ELIA, MH
HUTCHEON, AW
KAYE, SB
WINDSOR, PM
YOSEF, HMA
SHARP, L
机构
[1] NATL HLTH SERV SCOTLAND,DIV INFORMAT & STAT,EDINBURGH EH5 3SQ,MIDLOTHIAN,SCOTLAND
[2] RAIGMORE HOSP,DEPT RADIOTHERAPY & ONCOL,INVERNESS IV2 3UJ,SCOTLAND
[3] ABERDEEN ROYAL INFIRM,DEPT MED ONCOL,ABERDEEN AB9 2ZB,SCOTLAND
[4] CRC,DEPT MED ONCOL,GLASGOW G61 1BD,LANARK,SCOTLAND
[5] UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT RADIOTHERAPY & ONCOL,DUNDEE DD1 9SY,SCOTLAND
[6] UNIV GLASGOW,WESTERN INFIRM,BEATSON ONCOL CTR,GLASGOW G11 6NT,LANARK,SCOTLAND
关键词
AUDIT; NONSEMINOMATOUS GERM CELL TUMOR; MORTALITY; SCOTLAND; MANAGEMENT;
D O I
10.1038/bjc.1995.506
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A detailed casenote review was performed on 55 patients registered with testicular nonseminomatous germ cell tumours (NSGCT) between 1983 and 1988 under the Scottish Cancer Registration Scheme and who had died by 1992. Details of all aspects of clinical management relating to their NSGCT and death details were extracted and summarised. An assessment was made on whether the patients' management had been optimal. An analysis of 5 year survival rates by the five Scottish oncology centres demonstrated significant differences between centres (range 70.4-94.2; (2)(chi) = 14.46, d.f. = 4, P = 0.006). Some patients in all centres were assessed as having received suboptimal treatment, but two centres performed less well than the other three. There is a suggestion that the number of patients treated suboptimally decreases with increasing number of patients seen, but this does not reach statistical significance.
引用
收藏
页码:1307 / 1311
页数:5
相关论文
共 14 条
[1]  
ARMITAGE P, 1987, STATISTICAL METHODS
[2]   REFERRAL PATTERNS WITHIN SCOTLAND TO SPECIALIST ONCOLOGY CENTERS FOR PATIENTS WITH TESTICULAR GERM-CELL TUMORS [J].
CLARKE, K ;
HOWARD, GCW ;
ELIA, MH ;
HUTCHEON, AW ;
KAYE, SB ;
WINDSOR, PM ;
YOSEF, HMA .
BRITISH JOURNAL OF CANCER, 1995, 72 (05) :1300-1302
[3]   THE CURRENT MANAGEMENT OF TESTICULAR CANCER [J].
ELLIS, M ;
SIKORA, K .
BRITISH JOURNAL OF UROLOGY, 1987, 59 (01) :2-9
[4]   SURGICAL SALVAGE OF ADVANCED TESTICULAR-TUMORS [J].
EWING, R ;
HETHERINGTON, JW ;
JONES, WG ;
WILLIAMS, RE .
BRITISH JOURNAL OF UROLOGY, 1987, 59 (01) :76-80
[5]   MANAGEMENT OF MALIGNANT TERATOMA - DOES REFERRAL TO A SPECIALIST UNIT MATTER [J].
HARDING, MJ ;
PAUL, J ;
GILLIS, CR ;
KAYE, SB .
LANCET, 1993, 341 (8851) :999-1002
[6]   THE ROLE OF SURGERY IN THE COMBINED MANAGEMENT OF METASTASES FROM MALIGNANT TERATOMAS OF TESTIS [J].
HENDRY, WF ;
GOLDSTRAW, P ;
PECKHAM, MJ .
BRITISH JOURNAL OF UROLOGY, 1987, 59 (04) :358-358
[7]   A SCOTTISH NATIONAL AUDIT OF CURRENT PATTERNS OF MANAGEMENT FOR PATIENTS WITH TESTICULAR NONSEMINOMATOUS GERM-CELL TUMORS [J].
HOWARD, GCW ;
CLARKE, K ;
ELIA, MH ;
HUTCHEON, AW ;
KAYE, SB ;
WINDSOR, PM ;
YOSEF, HMA .
BRITISH JOURNAL OF CANCER, 1995, 72 (05) :1303-1306
[8]   THE 2ND MEDICAL-RESEARCH COUNCIL STUDY OF PROGNOSTIC FACTORS IN NONSEMINOMATOUS GERM-CELL TUMORS [J].
MEAD, GM ;
STENNING, SP ;
PARKINSON, MC ;
HORWICH, A ;
WILKINSON, FPM ;
KAYE, SB ;
NEWLANDS, ES ;
COOK, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :85-94
[9]  
PECKHAM MJ, 1979, LANCET, V2, P267
[10]  
Sharp L., 1993, Health Bulletin (Edinburgh), V51, P255